1. Field of the Invention
The present invention relates generally to implantation systems and in particular to an implantation system for tissue repair.
2. Description of Related Art
Currently, closure prostheses for repairing tears, cuts, holes or other imperfections in tissue operate by inserting two ends of a closure prosthesis into the tissue simultaneously, in effect “stapling” the prosthesis into place. Current methods for implanting closure prostheses lack provisions to increase precision in the delivery of the prosthesis and to increase control of implantation.
Chung et al. (U.S. Pat. No. 6,755,843) teaches an endoscopic suturing device. The suturing device includes a single needle that is configured to penetrate through tissue.
Hinchliffe (U.S. Pat. No. 5,527,321) teaches an instrument for closing puncture wounds. Hinchliffe teaches a device, including two pivoting needles. The tip of the device is inserted into a puncture wound. Following this, the needles are rotated from outside of the housing into tissue. At this point, the needles are caught within a latch member. Then, the device is pulled back through the puncture wound, along with the needles, so that the suture is pulled through the wound exiting at the open surface of the skin. The suture is then cut away from the needles and tied off.
Gordon et al. (U.S. Pat. No. 5,540,704) teaches an endoscopic suture system. Gordon teaches a pair of needles that are guided by a guiding track through tissue adjacent to a wound. Initially, the suturing device is inserted through a puncture wound. The guiding tracks are rotated to drive the needles through adjacent tissue. At this point, the needles are driven into a catch mechanism of the device. As the device is removed, the suture is pulled through the wound.
A method and apparatus for implanting a prosthesis for repairing tissue are disclosed. In one aspect, the invention provides a tissue repair system, comprising: a prosthesis including a first end portion and a second end portion; the first end portion including an engaging portion; the second end portion including a receiving portion that is configured to cooperate with the engaging portion; a delivery device configured to implant the prosthesis; the delivery device including a first delivery needle and a second delivery needle that are configured to penetrate through to a distal portion of a tissue, the distal portion of the tissue being disposed farther from a surgeon than a proximal portion of the tissue; the first delivery needle being associated with the engaging portion and the second delivery needle being associated with the receiving portion; and where the first delivery needle and the second delivery needle are configured to fasten the engaging portion to the receiving portion on the distal portion of the tissue.
In another aspect, the receiving portion includes a hole.
In another aspect, the engaging portion includes a catching member.
In another aspect, the prosthesis is a suture.
In another aspect, the engaging portion includes a knot.
In another aspect, the receiving portion includes a loop to receive the knot.
In another aspect, the invention provides a tissue repair system, comprising: a prosthesis including an engaging portion and a receiving portion; a delivery device configured to implant the prosthesis; the delivery device comprising a first delivery needle that is configured to move inward and a second delivery needle that is configured to move inward; the first delivery needle being associated with the engaging portion and the second delivery needle being associated with the receiving portion; and where the first delivery needle and the second delivery needle may move inward in a manner that aligns the engaging portion with the receiving portion.
In another aspect, the first delivery needle is associated with a first end portion and wherein the second delivery needle is associated with an intermediate portion disposed adjacent to a second end portion of the second delivery needle.
In another aspect, the first end portion of the first delivery needle is configured to align with the intermediate portion of the second delivery needle.
In another aspect, the first delivery needle and the second delivery needle are associated with an actuator that may be used to move the first delivery needle and the second delivery needle.
In another aspect, the actuator may be associated with a tensioning member that may be used to apply a force to control the actuator.
In another aspect, the first delivery needle includes an open channel.
In another aspect, the delivery device includes a pushing member disposed within the open channel and wherein the pushing member is configured to facilitate delivery of the prosthesis.
In another aspect, the invention provides a method of implanting a prosthesis, comprising the steps of: delivering a first end portion and a second end portion of a prosthesis on a distal portion of a tissue, where the distal portion is disposed farther from a surgeon than a proximal portion of the tissue; delivering an intermediate portion of a prosthesis to the proximal portion of the tissue; and fastening the first end portion to the second end portion.
In another aspect, the step of delivering the first end portion and the second end portion of the prosthesis includes a step of associating a delivery device with the tissue.
In another aspect, a portion of the delivery device is disposed within a cannula.
In another aspect, the step of fastening the first end portion to the second end portion includes a step of moving a first delivery needle of the delivery device and a second delivery needle of the delivery device inward.
In another aspect, the step of moving the first delivery needle and the second delivery needle includes a step of pulling a tensioning member inward.
In another aspect, the step of fastening includes a step of applying a force to at least one pushing member that is configured to contact a portion of the prosthesis.
In another aspect, the step of fastening is followed by a step of removing the delivery device.
Other systems, methods, features and advantages of the invention will be, or will become apparent to one with skill in the art upon examination of the following figures and detailed description. It is intended that all such additional systems, methods, features and advantages be included within this description, be within the scope of the invention, and be protected by the following claims.
The invention can be better understood with reference to the following drawings and description. The components in the figures are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the invention. Moreover, in the figures, like reference numerals designate corresponding parts throughout the different views.
Prosthesis 100 may comprise first end portion 102 and second end portion 104. In this embodiment, first end portion 102 is joined to second end portion 104 by intermediate portion 106. Generally, intermediate portion 106 may be configured with any length that allows prosthesis 100 to repair or improve an imperfection in tissue or retain it in a desired position. In some embodiments, intermediate portion 106 may provide a rigid connection between first end portion 102 and second end portion 104. In this preferred embodiment, however, intermediate portion 106 may be flexible and allow for relative motion of first end portion 102 with respect to second end portion 104.
Preferably, prosthesis 100 includes provisions for fastening first end portion 102 to second end portion 104. In this embodiment, first end portion 102 may include engaging portion 108. In particular, engaging portion 108 may be disposed on a length of first end portion 102. Similarly, second end portion 104 may include receiving portion 110. With this arrangement, prosthesis 100 may be fastened by inserting engaging portion 108 through receiving portion 110.
Engaging portion 108 may comprise a plurality of catching members. Generally, any type of catching or latching member known in the art can be used, such as uni-directional latching mechanisms. For example, a catching member can be a two-dimensional or three-dimensional protrusion configured to engage receiving portion 110 (
In some embodiments, engaging portion 108 may comprise a single catching member. In other embodiments, engaging portion 108 may comprise more than one catching member. In the current embodiment of
Generally, catching member set 120 of engaging portion 108 may be configured in any manner to engage receiving portion 110. In some cases, catching members from catching member set 120 may protrude with a rounded shape from first end portion 102. In other cases, the catching members of catching member set 120 may be constructed with a plurality of substantially triangular shapes projecting from first end portion 102. In the present embodiment of
Generally, receiving portion 110 may include any provisions for receiving engaging portion 108. In some embodiments, receiving portion 110 may be tied into a lasso knot to accommodate engaging portion 108. In a preferred embodiment, receiving portion 110 may include ring 151 with hole 153 to accommodate engaging portion 108. With this arrangement, receiving portion 110 may cooperate with engaging portion 108. In particular, catching members of catching member set 120 may be inserted through hole 153 of receiving portion 110. As the catching members of catching member set 120 are caught within hole 153, first end portion 102 may be fastened to second end portion 104.
Although one particular embodiment of prosthesis 100 is illustrated in
Prosthesis 100 may be made from one or more materials suitable for a suture including, but not limited to, chromic catgut, polyglycolic acid (PGA), or polydioxanone (PDS). In some embodiments, some portions of prosthesis 100 may be made of a generally rigid material while other portions of prosthesis 100 may be made of a generally flexible material. In some cases, first end portion 102 and second end portion 104 may be made of a generally rigid material. Likewise, intermediate portion 106 may be made of a generally flexible material. For example, prosthesis 100 may be made of materials including, but not limited to, metal or plastic. Using a rigid material for first end portion 102 and second end portion 104 and a flexible material for intermediate portion 106 may facilitate the fastening of prosthesis 100. In other embodiments, first end portion 102, second end portion 104 and intermediate portion 106 could all be made of a substantially similar material.
In other embodiments, however, prosthesis 100 could be made of other materials. In some cases, for example, it may be preferable to make prosthesis 100 using a biocompatible material that is sufficiently rigid to hold a cut or incision closed in some types of tissue, yet sufficiently compliant so as to avoid further damaging the tissue should slight relative motion between the tissue and prosthesis 100 occur. Examples of suitable materials include nylon, prolene, dacron, ultra high molecular weight polyethylene (UHMWPE), and other suitable suture materials.
In still other embodiments, prosthesis 100 may be formed of a bioabsorbable polymer that is gradually absorbed by the body. Some examples of suitable bioabsorbable materials are: poly L-lactic acid (PLLA) and polyglycolic acid (PGA). Prosthesis 100 can also be formed of other possible materials, including without limitation polytetrafluorethylene (PTFE), polyaryletherketone (PAEK), polyetheretherketone (PEEK), polyoxymethylene (acetal), polycarbonate, polysulfone, silicone elastomers, commercially pure titanium, titanium alloys, CoCr alloys, nickel titanium (nitinol) alloys and implant grade stainless steels.
Preferably, an imperfection in tissue may be repaired by implanting and fastening a prosthesis at the site of the imperfection, or a tissue may be retained proximate another tissue by implanting and fastening a prosthesis while the tissues are in their desired positions. In prior designs, a prosthesis implanted to repair or retain tissue may be fastened on a proximal portion of the tissue. The terms “proximal portion” as used throughout this detailed description and in the claims refers to a portion of a tissue that is disposed closest to a surgeon during implantation. Likewise, the term “distal portion” as used throughout this detailed description and in the claims refers to a portion of tissue disposed furthest from a surgeon during implantation.
In some cases, the fastening of a prosthesis on a proximal side of tissue may cause irritation that interferes with healing. For example, sutures are typically closed on a proximal side of tissue leaving small knots that can irritate adjacent tissue. In a preferred embodiment, a prosthesis may be fastened on a distal side of tissue. Preferably, fastening a prosthesis on a distal side of tissue prevents irritation on a proximal side of tissue and enhances healing.
As also shown in
In some cases, narrow retaining portion 195 can form a slot having a generally constant width. In the case shown in
In this embodiment, first end portion 102 is inserted through first tissue 201. In particular, first end portion 102 may be inserted through first proximal side 211 of first tissue 201 and emerge on first distal side 221 of first tissue 201. Additionally, second end portion 104 may be inserted through second tissue 202. In a similar manner to first end portion 102, second end portion 104 may pierce second proximal side 212 of tissue 202. Following this insertion, second end portion 104 may pass through second tissue 202 to emerge on second distal side 222 of second tissue 202. With this arrangement, first end portion 102 and second end portion 104 may be disposed on first distal side 221 and second distal side 222, respectively.
Referring to
Referring to
With this arrangement, prosthesis 100 may be fastened on first distal side 221 and second distal side 222 to hold first tissue 201 and second tissue 202 together. Furthermore, this method of fastening allows prosthesis 100 to be implanted with intermediate portion 106 disposed on first proximal side 211 and second proximal side 212. Preferably, intermediate portion 106 provides a smooth surface on first proximal side 211 and second side 212 to prevent irritation and improve healing.
Preferably, prosthesis 100 may be associated with a delivery device that can implant a prosthesis 100 at a proximal side of one or more tissues and fasten it on a distal side.
Referring to
Delivery device 400 preferably comprises several components configured to implant and fasten prosthesis 400 into some kind of tissue in need of repair. In this embodiment, delivery device 400 comprises first delivery needle 411 and second delivery needle 412. In some cases, first delivery needle 411 and second delivery needle 412 may be disposed within all or a portion of delivery lumen 402.
In some embodiments, first delivery needle 411 and second delivery needle 412 are generally hollow. In a preferred embodiment, first delivery needle 411 and second delivery needle 412 may be partially opened as seen in
Generally, first open channel 421 may extend throughout first intermediate portion 461 of first delivery needle 411. Likewise, second open channel 422 may extend throughout second intermediate portion 462 of second delivery needle 412. In other embodiments, first open channel 421 and second open channel 422 may extend through only parts of first intermediate portion 461 and second intermediate portion 462, respectively.
First delivery needle 411 and second delivery needle 412 can be piercing needles and can also include tapered ends configured to contact and navigate past tissue, and in some cases penetrate through tissue. In this embodiment, first delivery needle 411 and second delivery needle 412 may include first needle end 431 and second needle end 432, respectively. In a preferred embodiment, first needle end 431 and second needle end 432 are tapered to provide sharpened tips. In some cases, this tapered configuration of first needle end 431 and second needle end 432 may provide for wider openings of first open channel 421 and second open channel 422.
In some embodiments, first delivery needle 411 and second delivery needle 412 may be attached via an optional connector 450. In some cases, connector 450 may be attached to first delivery needle 411 and second delivery needle 412. This arrangement preferably provides structural stability and a rigid connection for first delivery needle 411 and second delivery needle 412. Furthermore, this arrangement of connector 450 may provide a pivoting point for first delivery needle 411 and second delivery needle 412.
Generally, connector 450 can be any type of structure that connects first delivery needle 411 and second delivery needle 412. In some embodiments, connector 450 can be a solid connector (see e.g.,
Connector 450 may be associated with any portion of first delivery needle 411 and second delivery needle 412. In some cases, connector 450 may be disposed near first needle end 431 and second needle end 432. Preferably, connector 450 may be disposed far away from first needle end 431 and second needle end 432.
Preferably, first delivery needle 411 and second delivery needle 412 may be configured to align first end portion 102 and second end portion 104 of prosthesis 100 in order to fasten prosthesis 100. In some embodiments, first delivery needle 411 and second delivery needle 412 may include first pivoting portion 471 and second pivoting portion 472, respectively. First pivoting portion 471 and second pivoting portion 472 may be configured to receive an actuating force that causes first delivery needle 411 and second delivery needle 412, respectively, to move towards one another to fasten first end portion 102 and second end portion 104 of prosthesis 100.
In some embodiments, first pivoting portion 471 and second pivoting portion 472 may receive an actuating force from actuator 485. In some cases, actuator 485 may include first portion 481 and second portion 482. In this embodiment, first pivoting portion 471 may be connected to first portion 481 of actuator 485. Likewise, second pivoting portion 472 may be connected to second portion 482 of actuator 485. Furthermore, first portion 481 and second portion 482 of actuator 485 may attach together at tensioning member 486. Preferably, tensioning member 486 may be manipulated by a surgeon to move actuator 485 and first pivoting portion 471 and second pivoting portion 472. With this configuration, actuator 485 may be used to control the motion of first delivery needle 411 and second delivery needle 412.
Generally, tensioning member 486 could be any device for applying tension to actuator 485. In some embodiments, tensioning member 486 could be a rod made of any substantially flexible material. In other embodiments, tensioning member 486 could be a cable of some kind. In yet other embodiments, tensioning member 486 can be substantially rigid and formed as a solid bar or tube made of a relatively stiff material. Tensioning member 486 can be a rod made of rigid material such as plastic or metal. In a preferred embodiment, tensioning member 486 is a stainless steel rod. With this arrangement, tensioning member 486 can easily be inserted through cannula 401 while providing enough stiffness to apply tension to actuator 485.
In this embodiment, actuator 485 may exert a first force on first pivoting portion 471 and second pivoting portion 472, when tensioning member 486 is pulled upward. In some cases, first portion 481 and second portion 482 may pull first delivery needle 411 and second delivery needle 412 inward to a closed position, when tensioning member 486 is pulled upward. In the closed position, first delivery needle 411 and second delivery needle 412 may be aligned to fasten first end portion 102 and second end portion 104. (See e.g.,
In some embodiments, actuator 485 may exert a second force on first pivoting portion 471 and second pivoting portion 472, when tensioning member 486 is pushed downward. (See e.g.,
Preferably, delivery device 400 includes provisions for applying a force for implantation and fastening of prosthesis 100. In some embodiments, delivery device 400 may be associated with first pushing member 491 and second pushing member 492. First pushing member 491 and second pushing member 492 are preferably configured to insert into first open channel 421 and second open channel 422, respectively. In addition, first pushing member 491 and second pushing member 492 may extend to a proximal end of delivery device 400 that is not visible in these Figures.
In a preferred embodiment, first pushing member 491 and second pushing member 492 are substantially rigid and configured to transfer a force applied at a proximal end of delivery device 400 to first distal end portion 493 and second distal end portion 494, respectively. With this arrangement, first pushing member 491 and second pushing member 492 may be used to transfer a force to prosthesis 100 that may assist in the fastening and implantation of prosthesis 100. In particular, first pushing member 491 may transfer a force to first end portion 102 and second pushing member 492 may transfer a force to second end portion 104.
In some embodiments, first end portion 102 and second end portion 104 may include provisions for receiving first pushing member 491 and second pushing member 492. In this preferred embodiment, first end portion 102 and second end portion 104 may include flattened portions 499 that are shaped to receive first pushing member 491 and second pushing member 492. This preferred arrangement may facilitate the implantation of first end portion 102 and second end portion 104 by first pushing member 491 and second pushing member 492, respectively.
In some embodiments, first pushing member 491 and second pushing member 492 may be rigidly connected using one or more connecting members. This arrangement may help apply forces to first end portion 102 and second end portion 104 simultaneously. In other embodiments, first pushing member 491 and second pushing member 492 may not be rigidly attached and may be capable of relative motion with respect to one another. In these embodiments, a force may be applied to first pushing member 491 and second pushing member 492 separately to fasten first end portion 102 and second end portion 104.
Generally, various different types of materials may be used for constructing delivery device 400. Preferably, first delivery needle 411 and second delivery needle 412 may be made of rigid materials. In some cases, rigid plastics may be used. In other cases, materials may be used that include some type of metal. In a preferred configuration, the delivery needles are made of stainless steel.
Referring to
Following the assembly of actuator 485, prosthesis 100 may be loaded into first delivery needle 411 and second delivery needle 412 such that prosthesis ends 102 and 104 are disposed within first and second open channels 421 and 422 respectively and intermediate portion 106 bridges between the needles. As shown in
In other embodiments, the needles could be rounded needles, such as needle 700 shown in
Returning to
Following the loading of prosthesis 100, first pushing member 491 and second pushing member 492 may be inserted into first open channel 421 and second open channel 422, respectively. At this point, delivery device 400, including first delivery needle 411 and second delivery needle 412 as well as prosthesis 100 may be inserted into delivery lumen 402.
It should be understood that the order of assembling the components of delivery device 400 is intended to be exemplary. In other embodiments, the order of assembly may vary. Additionally, it should be understood that delivery device 400 may be associated with delivery cannula 401 at various times. In some cases, delivery device 400 may be inserted into delivery lumen 402 of delivery cannula 401 prior to moving delivery cannula 401 into position near the tissue to be treated. In other cases, delivery device 400 may be inserted into delivery lumen 402 after moving delivery cannula 401 into position near the tissue to be treated.
It should be understood that the following embodiment is not intended to be limiting and other uses for prosthesis 100 and delivery device 400 will be apparent to anyone skilled in the art. As previously discussed, delivery device 400 may be used with any type of tissue that requires repair and that is configured to receive prosthesis 100. Furthermore, the following embodiment does not include steps for loading prosthesis 100 within delivery device 400, which have already been discussed in the previous embodiments.
Referring to
Preferably, at this point, prosthesis 100 is loaded within delivery device 400. In some cases, first delivery needle 411 and second delivery needle 412 may be disposed just within distal end portion 452. In addition, first delivery needle 411 and second delivery needle 412 may be configured in an open position.
Referring to
Following penetration into first tissue 601 and second tissue 602 by a desired amount, in a preferred embodiment a surgeon may pull tensioning member 486 away from delivery device 400 to apply a force to actuator 485 as seen in
As tensioning member 486 is pulled, actuator 485 is forced to contract. In particular, first portion 481 of actuator 485 and second portion 482 of actuator 485 may contract towards one another. This configuration conveys a force to first pivoting portion 471 of first delivery needle 411 and second pivoting portion 472 of second delivery needle 412. Preferably, this force causes first delivery needle 411 and second delivery needle 412 to move towards one another into a closed position in order to align and fasten prosthesis 100.
Generally, any portions of first delivery needle 411 and second delivery needle 412 may be aligned to fasten prosthesis 100. In some embodiments, first needle end 431 and second needle end 432 may be aligned in order to fasten prosthesis 100. In some cases, first needle end 431 may contact second needle end 432 to fasten prosthesis 100. In other cases, first needle end 431 may be slightly spaced apart from second needle end 432 in order to fasten prosthesis 100. In a preferred embodiment, first needle end 431 may align with second intermediate portion 462 in order to fasten prosthesis 100.
As shown in
Referring to
Referring to
In order to complete the implantation of prosthesis 100, delivery device 400 must fully release prosthesis 100. Referring to
As first delivery needle 411 and second delivery needle 412 open outward, prosthesis 100 may be released. In particular, the fastening of prosthesis 100 may provide tension so that prosthesis 100 is ejected from first open channel 421 and second open channel 422 as first delivery needle 411 and second delivery needle 412 open outward. In some cases, first pushing member 491 and second pushing member 492 may assist in pushing prosthesis 100 from first open channel 421 and second open channel 422. With this configuration, prosthesis 100 may be expelled from delivery device 400 and implanted within first tissue 601 and second tissue 602.
Referring to
In some embodiments, a delivery device for a prosthesis may be operated without the use of a delivery cannula. For example, in some cases a surgeon may repair a portion of tissue that is disposed close to the surface of the skin, such as a bone or tendon in a foot or a hand. In this case, the delivery device, including first delivery needle and second delivery needle, first pushing member and second pushing member, actuator mechanism and a prosthesis, may be directly associated with the tissue without the use of a delivery cannula. In particular, the delivery needles may be located at the treatment area and the pushing members may be used to fasten the prosthesis on a distal side of the tissue.
For clarity, the previous embodiments illustrated in
The configuration of prosthesis 900 can provide advantages for particular uses and insertion locations. For example, flat intermediate portion 906 can be beneficial for uses in which a low profile of the intermediate portion would be desirable, such as when disposed between translating tissues or within a tight space. Prosthesis 900 and thin intermediate portion 906 could provide benefits when placed at a spinal disk such that intermediate portion 906 would be disposed at an outer portion of the disk.
In addition, intermediate portion 906 can have various surface textures to provide particular features. For instance, outer surface 915 of intermediate portion 906 could be smooth to avoid irritating adjacent tissues that are expected to translate or otherwise move relative to the prosthesis during body movements. In other cases, outer surface 915 could have another texture, such as a rough texture that can enhance fit of the prosthesis with adjacent tissues. Inner surface 917 can also have other textures that can provided particular benefits, such as contours similar to nearby tissues, textures designed to encourage particular physiological responses in nearby tissues, or textures designed to adhere with adjacent tissues. In addition, inner and outer surfaces 915 and 917 can have geometric features, such as projections, nubs, and fastening features like hooks or loops, etc. As shown in
The reinforcing fibers can be made of the same types of materials noted above along with
While various embodiments of the invention have been described, the description is intended to be exemplary, rather than limiting and it will be apparent to those of ordinary skill in the art that many more embodiments and implementations are possible that are within the scope of the invention. Accordingly, the invention is not to be restricted except in light of the attached claims and their equivalents. Also, various modifications and changes may be made within the scope of the attached claims.
This application is a division of U.S. Patent Publication No. US 2011/0071548 (U.S. patent application Ser. No. 12/564,323, filed Sep. 22, 2009), now U.S. Pat. No. 8,211,126, issued Jul. 3, 2012, which is herein incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
2881762 | Lowrie | Apr 1959 | A |
3875595 | Froning | Apr 1975 | A |
4006747 | Kronenthal et al. | Feb 1977 | A |
4038987 | Komiya | Aug 1977 | A |
4235238 | Ogiu et al. | Nov 1980 | A |
4394864 | Sandhaus | Jul 1983 | A |
4448194 | DiGiovanni et al. | May 1984 | A |
4471181 | Dennison | Sep 1984 | A |
4533076 | Bourque | Aug 1985 | A |
4573448 | Kambin | Mar 1986 | A |
4621639 | Transue et al. | Nov 1986 | A |
4705040 | Mueller et al. | Nov 1987 | A |
4724840 | McVay et al. | Feb 1988 | A |
4873976 | Schreiber | Oct 1989 | A |
4877172 | Franklin et al. | Oct 1989 | A |
4884572 | Bays et al. | Dec 1989 | A |
4950285 | Wilk | Aug 1990 | A |
4997436 | Oberlander | Mar 1991 | A |
5002562 | Oberlander | Mar 1991 | A |
5085661 | Moss | Feb 1992 | A |
5154189 | Oberlander | Oct 1992 | A |
5192326 | Bao et al. | Mar 1993 | A |
5236440 | Hlavacek | Aug 1993 | A |
5281230 | Heidmueller | Jan 1994 | A |
5290296 | Phillips | Mar 1994 | A |
5290297 | Phillips | Mar 1994 | A |
5395317 | Kambin | Mar 1995 | A |
5403346 | Loeser | Apr 1995 | A |
5423857 | Rosenman et al. | Jun 1995 | A |
5425489 | Shichman et al. | Jun 1995 | A |
5439464 | Shapiro | Aug 1995 | A |
5439479 | Shichman et al. | Aug 1995 | A |
5465895 | Knodel et al. | Nov 1995 | A |
5470337 | Moss | Nov 1995 | A |
5500000 | Feagin et al. | Mar 1996 | A |
5527321 | Hinchliffe | Jun 1996 | A |
5540704 | Gordon et al. | Jul 1996 | A |
5549679 | Kuslich | Aug 1996 | A |
5591206 | Moufarrege | Jan 1997 | A |
5601571 | Moss | Feb 1997 | A |
5632433 | Grant et al. | May 1997 | A |
5643319 | Green et al. | Jul 1997 | A |
5653928 | Schnipke | Aug 1997 | A |
5716416 | Lin | Feb 1998 | A |
5817113 | Gifford, III et al. | Oct 1998 | A |
5827298 | Hart et al. | Oct 1998 | A |
5836147 | Schnipke | Nov 1998 | A |
5843084 | Hart et al. | Dec 1998 | A |
5860990 | Nobles et al. | Jan 1999 | A |
5931855 | Buncke | Aug 1999 | A |
5941439 | Kammerer et al. | Aug 1999 | A |
5954747 | Clark | Sep 1999 | A |
5972005 | Stalker et al. | Oct 1999 | A |
5976186 | Bao et al. | Nov 1999 | A |
5980504 | Sharkey et al. | Nov 1999 | A |
5993475 | Lin et al. | Nov 1999 | A |
5997552 | Person et al. | Dec 1999 | A |
6010513 | Tormala et al. | Jan 2000 | A |
6039753 | Meislin | Mar 2000 | A |
6074395 | Trott et al. | Jun 2000 | A |
6099514 | Sharkey et al. | Aug 2000 | A |
6110210 | Norton et al. | Aug 2000 | A |
6126670 | Walker et al. | Oct 2000 | A |
6126682 | Sharkey et al. | Oct 2000 | A |
6146387 | Trott et al. | Nov 2000 | A |
6183518 | Ross et al. | Feb 2001 | B1 |
6190401 | Green et al. | Feb 2001 | B1 |
6206921 | Guagliano et al. | Mar 2001 | B1 |
6206923 | Boyd et al. | Mar 2001 | B1 |
6241747 | Ruff | Jun 2001 | B1 |
6245107 | Ferree | Jun 2001 | B1 |
6264659 | Ross et al. | Jul 2001 | B1 |
6270517 | Brotz | Aug 2001 | B1 |
6280475 | Bao et al. | Aug 2001 | B1 |
6290715 | Sharkey et al. | Sep 2001 | B1 |
6306156 | Clark | Oct 2001 | B1 |
6318553 | Deschenes | Nov 2001 | B1 |
6322563 | Cummings et al. | Nov 2001 | B1 |
6332894 | Stalcup et al. | Dec 2001 | B1 |
6387113 | Hawkins et al. | May 2002 | B1 |
6387130 | Stone et al. | May 2002 | B1 |
6395031 | Foley et al. | May 2002 | B1 |
6402750 | Atkinson et al. | Jun 2002 | B1 |
6425919 | Lambrecht | Jul 2002 | B1 |
6427895 | Deschenes | Aug 2002 | B1 |
6428576 | Haldimann | Aug 2002 | B1 |
6443988 | Felt et al. | Sep 2002 | B2 |
6446854 | Remiszewski et al. | Sep 2002 | B1 |
6482235 | Lambrecht et al. | Nov 2002 | B1 |
6491724 | Ferree | Dec 2002 | B1 |
6497707 | Bowman et al. | Dec 2002 | B1 |
6508839 | Lambrecht et al. | Jan 2003 | B1 |
6517568 | Sharkey et al. | Feb 2003 | B1 |
6530933 | Yeung et al. | Mar 2003 | B1 |
6551343 | Tormala et al. | Apr 2003 | B1 |
6562033 | Shah et al. | May 2003 | B2 |
6564939 | Deschenes et al. | May 2003 | B1 |
6569369 | Shilale et al. | May 2003 | B2 |
6579291 | Keith et al. | Jun 2003 | B1 |
6592625 | Cauthen | Jul 2003 | B2 |
6596008 | Kambin | Jul 2003 | B1 |
6596014 | Levinson et al. | Jul 2003 | B2 |
6599310 | Leung et al. | Jul 2003 | B2 |
6602291 | Ray et al. | Aug 2003 | B1 |
6638276 | Sharkey et al. | Oct 2003 | B2 |
6676678 | Gifford, III et al. | Jan 2004 | B2 |
6682535 | Hoogland | Jan 2004 | B2 |
6685077 | Davignon et al. | Feb 2004 | B1 |
6689125 | Keith et al. | Feb 2004 | B1 |
6692499 | Tormala et al. | Feb 2004 | B2 |
6709442 | Miller et al. | Mar 2004 | B2 |
6719763 | Chung et al. | Apr 2004 | B2 |
6726685 | To et al. | Apr 2004 | B2 |
6733496 | Sharkey et al. | May 2004 | B2 |
6733531 | Trieu | May 2004 | B1 |
6736815 | Ginn | May 2004 | B2 |
6746685 | Williams | Jun 2004 | B2 |
6755843 | Chung et al. | Jun 2004 | B2 |
6776784 | Ginn | Aug 2004 | B2 |
6779701 | Bailly et al. | Aug 2004 | B2 |
6805695 | Keith et al. | Oct 2004 | B2 |
6848152 | Genova et al. | Feb 2005 | B2 |
7004970 | Cauthen, III et al. | Feb 2006 | B2 |
7052516 | Cauthen, III et al. | May 2006 | B2 |
7056330 | Gayton | Jun 2006 | B2 |
7189235 | Cauthen | Mar 2007 | B2 |
7338502 | Rosenblatt | Mar 2008 | B2 |
7547326 | Bhatnagar et al. | Jun 2009 | B2 |
7608108 | Bhatnagar et al. | Oct 2009 | B2 |
7632313 | Bhatnagar et al. | Dec 2009 | B2 |
8070818 | Bhatnagar et al. | Dec 2011 | B2 |
8177847 | Bhatnagar et al. | May 2012 | B2 |
20010004710 | Felt et al. | Jun 2001 | A1 |
20010010021 | Boyd et al. | Jul 2001 | A1 |
20020019626 | Sharkey et al. | Feb 2002 | A1 |
20020019636 | Ogilvie et al. | Feb 2002 | A1 |
20020022830 | Sharkey et al. | Feb 2002 | A1 |
20020026195 | Layne et al. | Feb 2002 | A1 |
20020068974 | Kuslich et al. | Jun 2002 | A1 |
20020111688 | Cauthen | Aug 2002 | A1 |
20020120337 | Cauthen | Aug 2002 | A1 |
20020123807 | Cauthen, III | Sep 2002 | A1 |
20020147461 | Aldrich et al. | Oct 2002 | A1 |
20020147479 | Aldrich | Oct 2002 | A1 |
20020147496 | Belef et al. | Oct 2002 | A1 |
20020147497 | Belef et al. | Oct 2002 | A1 |
20020151976 | Foley et al. | Oct 2002 | A1 |
20020151979 | Lambrecht et al. | Oct 2002 | A1 |
20020151980 | Cauthen | Oct 2002 | A1 |
20020156530 | Lambrecht et al. | Oct 2002 | A1 |
20020156531 | Felt et al. | Oct 2002 | A1 |
20020165542 | Ferree | Nov 2002 | A1 |
20020173851 | McKay | Nov 2002 | A1 |
20020183848 | Ray et al. | Dec 2002 | A1 |
20020189622 | Cauthen, III et al. | Dec 2002 | A1 |
20020198599 | Haldimann | Dec 2002 | A1 |
20030009227 | Lambrecht et al. | Jan 2003 | A1 |
20030014118 | Lambrecht et al. | Jan 2003 | A1 |
20030014177 | Herb et al. | Jan 2003 | A1 |
20030028251 | Mathews | Feb 2003 | A1 |
20030040796 | Ferree | Feb 2003 | A1 |
20030069641 | Reuter et al. | Apr 2003 | A1 |
20030074075 | Thomas, Jr. et al. | Apr 2003 | A1 |
20030078579 | Ferree | Apr 2003 | A1 |
20030082169 | Boyd | May 2003 | A1 |
20030083642 | Boyd et al. | May 2003 | A1 |
20030093155 | Lambrecht et al. | May 2003 | A1 |
20030114930 | Lim et al. | Jun 2003 | A1 |
20030120345 | Cauthen | Jun 2003 | A1 |
20030125748 | Li et al. | Jul 2003 | A1 |
20030125807 | Lambrecht et al. | Jul 2003 | A1 |
20030153976 | Cauthen, III et al. | Aug 2003 | A1 |
20030158604 | Cauthen, III et al. | Aug 2003 | A1 |
20030163200 | Cauthen | Aug 2003 | A1 |
20030167055 | Kolata et al. | Sep 2003 | A1 |
20030181964 | Sharkey et al. | Sep 2003 | A1 |
20030181983 | Cauthen | Sep 2003 | A1 |
20030187445 | Keith et al. | Oct 2003 | A1 |
20030187507 | Cauthen | Oct 2003 | A1 |
20030187508 | Cauthen | Oct 2003 | A1 |
20030191436 | Horvers | Oct 2003 | A1 |
20030195514 | Trieu et al. | Oct 2003 | A1 |
20030195628 | Bao et al. | Oct 2003 | A1 |
20030195630 | Ferree | Oct 2003 | A1 |
20030199979 | McGuckin, Jr. | Oct 2003 | A1 |
20030199984 | Trieu | Oct 2003 | A1 |
20030220649 | Bao et al. | Nov 2003 | A1 |
20030220690 | Cauthen, III | Nov 2003 | A1 |
20030220693 | Cauthen, III | Nov 2003 | A1 |
20030220694 | Cauthen, III | Nov 2003 | A1 |
20030220695 | Sevrain | Nov 2003 | A1 |
20040002746 | Ryan et al. | Jan 2004 | A1 |
20040002760 | Boyd et al. | Jan 2004 | A1 |
20040002763 | Phillips et al. | Jan 2004 | A1 |
20040002764 | Gainor et al. | Jan 2004 | A1 |
20040010317 | Lambrecht et al. | Jan 2004 | A1 |
20040019381 | Pflueger | Jan 2004 | A1 |
20040024463 | Thomas, Jr. et al. | Feb 2004 | A1 |
20040024465 | Lambrecht et al. | Feb 2004 | A1 |
20040030392 | Lambrecht et al. | Feb 2004 | A1 |
20040034429 | Lambrecht et al. | Feb 2004 | A1 |
20040039392 | Trieu | Feb 2004 | A1 |
20040044412 | Lambrecht et al. | Mar 2004 | A1 |
20040059417 | Smith et al. | Mar 2004 | A1 |
20040059418 | McKay et al. | Mar 2004 | A1 |
20040064023 | Ryan et al. | Apr 2004 | A1 |
20040068268 | Boyd et al. | Apr 2004 | A1 |
20040073308 | Kuslich et al. | Apr 2004 | A1 |
20040083002 | Belef et al. | Apr 2004 | A1 |
20040092933 | Shaolian et al. | May 2004 | A1 |
20040092945 | Ferree | May 2004 | A1 |
20040097924 | Lambrecht et al. | May 2004 | A1 |
20040097980 | Ferree | May 2004 | A1 |
20040102774 | Trieu | May 2004 | A1 |
20040267309 | Garvin | Dec 2004 | A1 |
20050055027 | Yeung et al. | Mar 2005 | A1 |
20050070924 | Schaller et al. | Mar 2005 | A1 |
20060247643 | Bhatnagar et al. | Nov 2006 | A1 |
20070088438 | Cauthen, III et al. | Apr 2007 | A1 |
20070100348 | Cauthen, III et al. | May 2007 | A1 |
20070100354 | Cauthen, III et al. | May 2007 | A1 |
20070149987 | Wellman et al. | Jun 2007 | A1 |
20070185497 | Cauthen et al. | Aug 2007 | A1 |
20090118734 | Bhatnagar et al. | May 2009 | A1 |
20110071548 | Yeh et al. | Mar 2011 | A1 |
Number | Date | Country |
---|---|---|
2651113 | Mar 1991 | FR |
02058599 | Aug 2002 | WO |
2006118930 | Nov 2006 | WO |
Entry |
---|
International Search Report and Written Opinion mailed Apr. 23, 2008 in PCT Application No. PCT/US2006/015960. |
International Search Report and the Written Opinion of the International Searching Authority, mailed Jan. 17, 2011 in PCT Application No. PCT/US2010/049613. |
Notification Concerning Transmittal of International Preliminary Report on Patentability, mailed Apr. 9, 2009 in PCT Application No. PCT/US2006/015960. |
Office Action from U.S. Appl. No. 11/934,737, mailed May 11, 2011. |
Response to Office Action filed on Jul. 25, 2011 for U.S. Appl. No. 11/934,737. |
Decision Granting Petition from U.S. Appl. No. 11/934,737, mailed Aug. 24, 2011. |
Final Office Action from U.S. Appl. No. 11/934,737, mailed Dec. 20, 2011. |
Amendment Accompanying Request for Continued Examination filed on May 21, 2012 for U.S. Appl. No. 11/934,737. |
Request for Continued Examination filed May 21, 2012 for U.S. Appl. No. 11/934,737. |
Office Action from U.S. Appl. No. 12/413,113, mailed Jun. 30, 2011. |
Response to Office Action filed on Sep. 22, 2011 for U.S. Appl. No. 12/413,113. |
Notice of Allowance from U.S. Appl. No. 12/413,113 mailed Oct. 7, 2011. |
Notice of Allowance from U.S. Appl. No. 12/612,970 mailed Sep. 28, 2011. |
Request for Continued Examination filed on Nov. 2, 2011 for U.S. Appl. No. 12/612,970. |
Notice of Allowance from U.S. Appl. No. 12/612,970 mailed Dec. 16, 2011. |
Number | Date | Country | |
---|---|---|---|
20120232586 A1 | Sep 2012 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12564323 | Sep 2009 | US |
Child | 13473340 | US |